In March, two biotechnology companies were given the greenlight by the Food and Drug Administration, or FDA, to conduct trials transplanting genetically-modifie ...

United Therapeutics Corporation ... which are development-stage organ products. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable ...

Previous skepticism turns to optimism as the first clinical trials for transplantation with genetically edited pig kidneys ...

New home of UBC's School of Biomedical Engineering will advance health solutions and grow Canada's biotech sectorToday, the ...

Cidara Therapeutics (NASDAQ:CDTX – Get Free Report) and Creative Medical Technology (NASDAQ:CELZ – Get Free Report) are both small-cap medical companies, but which is the better business? We will ...

BEIJING, CN / ACCESS Newswire / April 3, 2025 / CASI Pharmaceuticals, Inc. (Nasdaq:CASI, "CASI"), a Cayman incorporated biopharmaceutical company focused on developing and commercializing innovative ...

Home > Press release: The 2025 Else Kröner Fresenius Prize for ...

According to the publisher's analysis, the kidney transplant rejection market in the 7MM was valued at approximately USD 3.97 billion in 2023. Over the forecast period from 2024 to 2034, this market ...

Amgen (NASDAQ:AMGN) announced today that the U.S. Food and Drug Administration (FDA) has approved UPLIZNA as the first and onl ...

The first patient with locally advanced rectal cancer has been enrolled in the FORTRESS study which is evaluating the ...